Ioannis Parodis, MD, PhD, Karolinska Institutet, Sweden
Dr Ioannis Parodis studied Medicine at the National and Kapodistrian University of Athens, Greece, and graduated in 2006. He has an interest in B cell biology and novel treatments for systemic lupus erythematosus and lupus nephritis. Currently, Dr Parodis holds a permanent position as a senior consultant Rheumatologist at the Karolinska University Hospital in Stockholm, Sweden, and educational leadership positions at the medical program of Karolinska Institutet. His research has focused on identifying biomarkers and calibrating predictive models for diagnostics, clinical and immune responses to therapies, and long-term prognosis in systemic lupus erythematosus and lupus nephritis. Since 2021, Dr Parodis is also affiliated with the Örebro University, Örebro, Sweden.
Chang-Hee Suh, MD, PhD, Ajou University School of Medicine, South Korea
Dr Chang-Hee Suh is a professor and director of Rheumatology at Ajou University School of Medicine serving in these capacities since March 2011. He is also a professor in the Department of Molecular Science and Technology at Ajou University serving in this role since February 2020. He obtained his MD and PhD in Rheumatology from Yonsei University, Seoul, South Korea. Dr Suh worked as a postdoctoral fellow in the Department of Rheumatology at the University of Pennsylvania. He has published more than 330 peer-reviewed articles with more than 7,000 citations. His research interest is the biomarkers in lupus and the development of new disease-specific treatments in autoimmune diseases.
Fangfang Sun, MD, Renji Hospital, Shanghai Jiaotong University, China
Dr Sun is an associate professor of Rheumatology at Renji Hospital, Shanghai Jiaotong University in China. She completed her MD studies at Peking Union Medical College and conducted her postdoctoral research in the Center of Rheumatology, University Zurich Hospital. Her research includes risk factors, comorbidities, personalized disease management, and flare prevention of SLE with cohort studies and randomized controlled trials. She works as a youth member of the Rheumatology Division of Shanghai Medical Association.
Jiuliang Zhao, MD, Peking Union Medical College Hospital, China
Dr Jiuliang Zhao is a professor of Rheumatology and deputy director of the Department of Rheumatology and Clinical Immunology at Peking Union Medical College Hospital (PUMCH), which has long been considered the top one hospital in China. Dr Zhao’s major research interests are pathogenesis and clinical studies for systemic lupus erythematosus and antiphospholipid syndrome. His team has established a prospective multicenter cohort Chinese SLE Treatment and Research group (CSTAR) comprising over 5,000 lupus patients. Dr Zhao has authored 53 articles as either the first/co-first author or the corresponding author in journals such as Autoimmunity Reviews, Pharmacology & Therapeutics, Rheumatology (Oxford), RMD Open, and Lupus. Dr Zhao serves as a vice president of the Chinese Rheumatology Association (CRA) Young Committee, and vice president of the Asia Pacific League of Associations for Rheumatology (APLAR) Young Rheumatologist Committee.
